Conversion Therapy of RAS/BRAF Wild-Type Right-Sided Colon Cancer Patients With Initially Unresectable Liver Metastases
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2696397
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Group 1:FOLFOX+Cetuximab;Group 2:FOLFOX + bevacizumab
Primary outcome(s): conversion-to-resection rate
Study Design: Parallel
创建时间：
2020-10-15
